Vaccine News and Research

Latest Vaccine News and Research

Merck partners with non-profit for neglected diseases initiative

The pharmaceutical company, Merck, announced Monday it was partnering with the non-profit Drugs for Neglected Diseases initiative (DNDi) in an effort to improve treatments for neglected tropical diseases (NTD), the AP/CNBC reports.

23 Jun 2009

Number of Polio cases in Nigeria decreases, some states still showing low immunizations rates

The number of polio cases in Nigeria has gone down from 799 in 2008 to 353 this year, according to the country's National Primary Health Care Development Agency (NPHCDA), Africa Science News Service reports.

23 Jun 2009

Scientists block Ebola infection in cell-culture experiments - could lead to first therapy

Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells.

23 Jun 2009

New tuberculosis drug targets

A fundamental question about how sugar units are strung together into long carbohydrate chains has also pinpointed a promising way to target new medicines against tuberculosis.

23 Jun 2009

Ban Ki-Moon calls on governments to eradicate polio

U.N. Secretary General Ban Ki-moon on Sunday at the Rotary International (RI) Annual Convention in Birmingham, U.K., said that governments worldwide should continue to work towards eradicating polio, BBC reports.

22 Jun 2009

Transplant drug Rapamycin stimulates immune memory

Rapamycin, a drug given to transplant recipients to suppress their immune systems, has a paradoxical effect on cells responsible for immune memory, scientists at the Emory Vaccine Center have discovered.

22 Jun 2009

Discovery on HIV replication may lead to new therapies

Researchers from the newly-established VGTI Florida and the University of Montreal have uncovered a possible method for eradicating HIV infection in the human body.

22 Jun 2009

Adults with asthma not getting their flu shots

Because of increased risk of complications from influenza, vaccination of adults and children with asthma is recommended by the Advisory Committee on Immunization Practices.

22 Jun 2009

New discovery on how botulism paralyzes nerve cells

New structures of a botulism toxin interacting with a mimic of the nerve-cell protein it destroys suggest new ways to block this often-fatal interaction. Indeed, the mimic molecules have such high affinity for the toxin and bind to it so tightly that they themselves could possibly serve as anti-toxin drugs with further modification, the researchers said.

21 Jun 2009

Economist examines schistosomiasis in China

The Economist examines schistosomiasis in China. The disease, which is also called snail-fever, is the "world’s second-most prevalent tropical disease after malaria, affecting 207 million people of whom 726,000 are Chinese, according to the most recent official figures, from 2004," the Economist reports.

21 Jun 2009

Some call for more action at conclusion of Pacific Health Summit

Some Pacific Health Summit attendees said more action should have come from the tuberculosis-focused conference, which ended on Thursday in Seattle, Seattle Times' "Business of Giving" blog reports.

21 Jun 2009

U.S. flu funds; South Africa confirms first case; EU encouraged to coordinate pandemic vaccine policy

The U.S. Senate on Thursday passed a $105.9 billion war-funding bill that "includes $7.7 billion to prepare for pandemic flu," the Washington Post reports (Bacon, Washington Post, 6/19).

21 Jun 2009

Lancet studies examine aspects of global health funding

"Global health funding boosted by private donors has quadrupled since 1990, but the extra money has not always gone to the right countries and diseases, according to a pair of studies released Friday," in the journal Lancet, AFP/Google.com reports (Hood, AFP/Google.com, 6/18).

21 Jun 2009

Sanofi-Aventis, GlaxoSmithKline will donate influenza vaccines to WHO

The drugmaker Sanofi-Aventis will donate millions of doses of a vaccine that offers protection against the H1N1 (swine flu) virus to the WHO once the vaccine is ready, the company's chief executive officer announced Tuesday, Reuters reports (Elsner, Reuters, 6/17).

18 Jun 2009

Globe and Mail examines GlaxoSmithKline's RTS,S malaria vaccine trials in Kenya

The Globe and Mail examines GlaxoSmithKline's RTS,S malaria vaccine trials in Kilifi, Kenya – one of the sites where the experimental vaccine is being tested. "The stories of the mothers of Kilifi open a window on the challenges faced by researchers as they build a trial that will include more than 16,000 babies from 11 sites spread across sub-Saharan Africa," the Globe and Mail reports.

18 Jun 2009

Targeting children may be an effective use of limited supplies of flu vaccine

Targeting children may be an effective use of limited supplies of flu vaccine, according to research funded by the Wellcome Trust and the EU. The study suggests that, used to support other control measures, this could help control the spread of pandemics such as the current swine flu.

17 Jun 2009

Cholesterol-lowering statin drugs do not lower risk of pneumonia in seniors

Taking popular cholesterol-lowering statin drugs, such as Lipitor (atorvastatin), does not lower the risk of pneumonia. That's the new finding from a study of more than 3,000 Group Health patients published online on June 16 in advance of the British Medical Journal's June 20 print issue.

17 Jun 2009

Household structure and infectious disease transmission

Targeting children may be an effective use of limited supplies of flu vaccine, according to research at the University of Warwick funded by the Wellcome Trust and the EU. The study suggests that, used to support other control measures, this could help control the spread of pandemics such as the current swine flu.

17 Jun 2009

Preventing spread of infectious diseases is everyone’s responsibility – and everyone’s job

According to a report published today, we must all share responsibility for preventing the spread of diseases such as swine flu, SARS, avian influenza, diarrhoeal and skin diseases, and even the common cold.

16 Jun 2009

Pneumococcal vaccine effective in preventing severe pneumonia

A new trial has found that pneumococcal vaccine is effective in preventing severe pneumonia, the leading cause of death among children in developing countries. Co-ordinated by the National Institute for Health and Welfare (THL) between 2000 and 2004, a large scale efficacy trial - first of its kind in Asia - was carried out in the Philippines to investigate the effect of an investigational pneumococcal vaccine.

16 Jun 2009